Because estrogen replacement therapy (ERT) alone is associated with an increased risk of endometrial cancer (cancer of the lining of the uterus), women who still have a uterus are given hormone replacement therapy (HRT)—estrogen plus progesterone—which provides the benefits of estrogen without the increased risk of endometrial cancer.